- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
11. The following provisions shall be revoked—
(a)Part IIIA (that is, regulation 9A) (capital fees for renewals of certain product licences) of, and paragraph 2A of Schedule 4 (time for payment of capital fees—applications made by small companies) to, the principal Regulations, and
(b)regulations 4 (insertion of Part IIIA into the principal Regulations) and 11 (amendment of Schedule 4 to the principal Regulations) of the Medicines (Products for Human Use-Fees) Regulations 1992(1).
S.I. 1992/756.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: